title: The effect of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in female rats during the estrous cycle.
abstract: Prolactin (PRL) release induced by TRH was examined on each day of the estrous cycle in female rats in which pituitary dopamine (DA) receptors were blocked pharmacologically. The objective was to determine if an interaction exists between hypothalamic inhibitory and releasing hormones with regard to prolactin (PRL) secretion. Domperidone (0.01 mg/rat i.v.) followed 5 minutes later by the administration of the DA agonist 2-Br-alpha-ergocryptine maleate (CB-154, 0.5 mg/rat i.v.) were used to produce a transient (less than 1 hr) dopamine blockade. One hour later, thyrotropin-releasing hormone (TRH, 1.0 microgram/rat i.v.) was given to stimulate PRL release. On the morning of proestrus, TRH released a significantly greater quantity of PRL into the plasma after DA antagonism compared to control animals which did not receive the dopamine antagonist. Dopamine antagonism also enhanced the effectiveness of TRH on the mornings of estrus and metestrus. The response on estrus was significantly greater than the response on proestrus. However by the morning of diestrus, TRH-"releasable" PRL was greatly diminished. Our results suggest that DA antagonism is able to shift differing quantities of PRL into a TRH "releasable" pool on several days of the estrous cycle and that the control of this mechanism is acute.
authors.affiliation: Department of Physiology, Wayne State University, Detroit, MI 48201.
authors.forename: D J
authors.initials: DJ
authors.lastname: Haisenleder
authors.forename: R R
authors.initials: RR
authors.lastname: Gala
authors.forename: D M
authors.initials: DM
authors.lastname: Lawson
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D004294:Domperidone / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004873:Ergolines / Q000008:administration & dosage; D004971:Estrus / Q000187:drug effects*; D005260:Female; D010902:Pituitary Gland / Q000187:drug effects; D011388:Prolactin / Q000378:metabolism*; D011863:Radioimmunoassay; D051381:Rats; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
chemical_list: D018492:Dopamine Antagonists; D004873:Ergolines; C100269:ergocryptine; D004294:Domperidone; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin